Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 584.70, up by 4.10 points or 0.71% from its previous closing of Rs. 580.60 on the BSE.

The scrip opened at Rs. 580.60 and has touched a high and low of Rs. 587.00 and Rs. 579.85 respectively. So far 18847 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 653.10 on 03-Mar-2014 and a 52 week low of Rs. 405.50 on 01-Apr-2013.

Last one week high and low of the scrip stood at Rs. 595.90 and Rs. 572.00 respectively. The current market cap of the company is Rs. 121163.09 crore.

The promoters holding in the company stood at 63.65% while Institutions and Non-Institutions held 28.23% and 8.11% respectively.

Sun Pharmaceutical Industries has received National Stock Exchange’s (NSE) approval to merge ‘specified therapeutic and investment’ business of its subsidiary into itself. As per norms, companies seeking to execute merger or de-merger strategies need to obtain a 'no-objection certificate' from stock exchanges.

In November 2013, the company already received its board’s approval to transfer ‘specified therapeutic and investment’ business, a part of Sun Pharma Global FZE, into itself.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.